Journal of Gynecologic Oncology

Article	Citations
Prognostic influence of an early time to chemotherapy following primary cytoreductive surgery for advanced epithelial ovarian cancer	123
Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and over	45
Missing a chance to prevent: disparities in completion of genetic evaluation in high-risk patients with endometrial cancer	44
Nomogram for predicting pathology upstaging in patients with EIN: is sentinel lymph node assessment useful in these patients?	36
Evaluation of secondary cytoreduction surgery in platinum-resistant ovarian cancer patients within three-line recurrent: a multicenter, randomized controlled study	36
Pregnancy complications and outcomes in patients with early endometrial cancer or atypical hyperplasia after fertility-sparing treatment	34
Developing standardized informed consent for hysterectomy and vulva cancer surgery	32
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey	29
Practice guideline for management of endometrial cancer in Thailand: a Thai Gynecologic Cancer Society consensus statement	28
Increased cardiovascular disease risk among adolescent and young adult survivors of cervical cancer	25
Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity	24
Laparoscopic radical hysterectomy without uterine manipulator or vaginal tube use	23
The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial	23
Para-aortic lymph node dissection with or without nerve-sparing in gynecological malignancies	22
Impact of adjuvant chemotherapy on the overall survival of patients with resectable bulky small cell neuroendocrine cervical cancer: a JSGO-JSOG joint study	21
Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis	20
Fertility-sparing treatment outcomes using immune checkpoint inhibitors in endometrial cancer patients with Lynch syndrome	19
Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review	18
Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective,	18
The 7th Biennial Meeting of the Asian Society of Gynecologic Oncology, November 25th to 27th, 2021	17
Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy	16
Efficacy of edoxaban for the treatment of gynecological cancer-associated venous thromboembolism: analysis of Japanese real-world data	16
Salvage hysterectomy for persistent residual cervical cancer: assessment of prognostic factors	16
Current peritonectomy practice during debulking surgery in patients with newly diagnosed advanced ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 4004)	15
A step towards the ambition of precision oncology in recurrent ovarian cancer	15

Evaluation of the role of liver metastasectomy in the treatment of stage IV endometrial cancer	15
Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset	15
Functions, interactions and prognostic role of POLE: a bioinformatics analysis	15
RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma	14
Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multice	14
Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan	14
Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer	13
Enrichment for the POLE mutated against p53 wild subtype using clinicopathologic factors and cyclin B1 immunohistochemistry in endometrial cancer	13
Prognostic significance of heterologous component in carcinosarcoma of the gynecologic organs: a systematic review and meta-analysis	13
Olaparib plus bevacizumab as a first-line maintenance treatment for patients with advanced ovarian cancer by molecular status: an updated PAOLA-1 based cost-effectiveness analysis	13
East Asian Gynecologic Oncology Trial Group (EAGOT): founding history and future perspective	13
A multimodal intervention program to improve sexual health and self-perceived quality of life in patients treated for cervical cancer: a randomized prospective study (PROVIDENCE trial)	12
Cervical screening among Chinese females in the era of HPV vaccination: a population-based survey on screening uptake and regular screening following an 18-year organized screening program	12
Risk of CIN2+ in women aged >60 years with abnormal cervical cancer screening: a multicenter retrospective cohort study from the Thai Gynecologic Cancer Society research group	12
Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer	12
Diagnostic accuracy and prognostic factors of uterine serous carcinoma in Japanese women: a multi-center study	12
Supragastric lesser sac: an insidious site for surgical exploration during the debulking surgery in advanced ovarian cancer	12
Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial)	12
Immunotherapy plus chemotherapy in patients with advanced endometrial cancer: a cost-effectiveness analysis	12
Efficacy and toxicity of PARP inhibitor in elderly patients with homologous recombination-deficient newly diagnosed advanced ovarian cancer: the role of dose modification	12
Development of a prognostic prediction support system for cervical intraepithelial neoplasia using artificial intelligence-based diagnosis	11
Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system	11
A prospective comparison of the diagnostic accuracies of ultrasound and magnetic resonance imaging in preoperative staging of endometrial cancer	11
Transabdominal cardiophrenic lymph node dissection for cytoreductive surgery in advanced ovarian cancer	10
Implementation rate and related factors of confirmatory tests following an abnormal Pap smear: a nationwide study from the National Health Insurance	10
Adjuvant pelvic radiation versus observation in intermediate-risk early-stage cervical cancer patients following primary radical surgery: a propensity score-adjusted analysis	10
Adjuvant carboplatin and paclitaxel with “sandwich” method radiotherapy for stage III or IV endometrial cancer: long-term follow-up at a single-institution	10
Emergency craniotomy: a life-saving procedure as part of multi-modal therapy of GTN	10
Preoperative serum microRNAs as potential prognostic biomarkers in ovarian clear cell carcinoma	10
Incidence and risk factors for the development of cerebral metastasis in cervical cancer patients	10
Cost-effectiveness analysis of hospital treatment volume and survival outcomes in endometrial cancer in Japan	9
Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy	9
Clinical implications of the superficial uterine vein pattern for the dissection of the anterior layer of the vesicouterine ligament in radical hysterectomy	9
Identification of the prognostic immune subtype in copy-number high endometrial cancer	9
Navigating the future of fertility preservation: advanced predictive strategies for treatment outcomes of endometrial atypical hyperplasia and carcinoma	8
Differentiation of uterine fibroids and sarcomas by MRI and serum LDH levels: a multicenter study of the KAMOGAWA study	8
Cost-effectiveness of atezolizumab plus chemotherapy for advanced/recurrent endometrial cancer	8
HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma	8
Intra- and postoperative complications associated with diaphragmatic surgery for advanced ovarian cancer	8
Humanized patient-derived xenograft mouse model bearing ovarian clear cell carcinoma	8
Confirmation of the utility of the CA-125 elimination rate (KELIM) as an indicator of the chemosensitivity in advanced-stage ovarian cancer in a “real-life setting”	8
Validation of HPV triage in cytology-based cervical cancer screening for ASC-US cases using Japanese data	7
Risk of ovarian cancer in women with pelvic inflammatory disease and homologous recombination repair gene mutations under 55: a population-based cohort study	7
RAIDS atlas of significant genetic and protein biomarkers in cervical cancer	7
Laparoscopy-assisted laterally extended endopelvic resection and sacrectomy (beyond laterally extended endopelvic resection) for platinum-sensitive recurrent ovarian cancer	7
Reviewer recognition in 2024	7
Bevacizumab combined with chemotherapy could be superior to chemotherapy alone in relapsed ovarian cancer after PARPi: evidence from a multi-center propensity score-matched analysis	7
The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma	7
Development and validation of a prognostic model based on metabolic risk score to predict overall survival of endometrial cancer in Chinese patients	7
Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups	7

A phase II trial evaluating the efficacy and safety of repeated high dose medroxyprogesterone acetate (MPA) therapy for patients with recurrent early-stage endometrial cancer or atypical endometrial h	7
Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia	7
Alternative splicing of PSMD13 mediated by genetic variants is significantly associated with endometrial cancer risk	7
Protective ostomies in ovarian cancer surgery: a systematic review and meta-analysis	7
Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening	7
Prognostic value of complete metabolic response on 18F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer	7
The sealing effect of magnetic-sealing uterine manipulator in isolated uterus from patients with early-stage cervical cancer: a pre-clinical study	7
LncRNA linc01194 promotes the progress of endometrial carcinoma by up-regulating SOX2 through binding to IGF2BP1	7
Evolving standards and future directions for systemic therapies in cervical cancer	7
The necessity of adjuvant surgery for patients with high-risk chemorefractory or relapsed gestational choriocarcinoma with complete remission after anti-PD-1 therapy	7
The SHAPE trial: is good is good enough?	6
Comparison of carboplatin-based chemotherapy versus cisplatin-based chemotherapy in the treatment of malignant gonadal germ cell tumor: a systematic review and meta-analysis	6
Clinical practice guidelines for cervical cancer: an update of the Korean Society of Gynecologic Oncology Guidelines	6
Sentinel node mapping in endometrial cancer	6
Platinum free interval and clinical benefit of the second-line chemotherapy in recurrent uterine and ovarian carcinosarcoma: a retrospective cohort analysis	6
Can surgery boost the survival benefit of chemoradiotherapy in T1b1-T2a1 stage cervical cancer with lymph node metastasis? A population-based study	6
Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer	6
Asian Society of Gynecologic Oncology (ASGO) 2024 Annual Meeting in Bali, Indonesia	6
Incidence and treatment outcomes of uterine cervical cancer in Korea 1999–2018 from the national cancer registry	6
Comparison of progression-free survival outcome of sentinel node biopsy without ultrastaging versus lymphadenectomy in endometrial cancer: a propensity-matched analysis	6
Cancer-field surgery for endometrial cancer by robotic peritoneal mesometrial resection and targeted compartmental lymphadenectomy (PMMR+TCL)	6
The 8th Biennial Meeting of the Asian Society of Gynecologic Oncology, December 1st to 3rd, 2023	6
Th2 cells infiltrating high-grade serous ovarian cancer: a feature that may account for the poor prognosis	6
Molecular classification of endometrial cancer: entering an era of precision medicine	5
Mutations in homologous recombination repair genes in patients with metastatic endometrial cancer: association with clinical characteristics and prognosis	5
TP53 variants in p53 signatures and the clonality of STICs in RRSO samples	5
CircSMAD2 accelerates endometrial cancer cell proliferation and metastasis by regulating the miR-1277-5p/MFGE8 axis	5
Bispecific immunotherapy MEDI5752 or volrustomig and cervical cancer	5
Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications	5
Prognostic values of tumor size and location in early stage endometrial cancer patients who received radiotherapy	5
Minimally invasive radical hysterectomy and the importance of avoiding cancer cell spillage for early-stage cervical cancer: a narrative review	5
Prevalence and prognostic value of PD-L1 expression and tumor mutational burden in persistent, recurrent, or metastatic cervical cancer	5
Targeting BRAF pathway in low-grade serous ovarian cancer	5
Prevention of symptomatic pulmonary embolism for gynecologic malignancies with preoperative asymptomatic venous thromboembolism: GOTIC-VTE trial	5
Rotational intraperitoneal pressurized aerosol chemotherapy with paclitaxel and cisplatin: pharmacokinetics, tissue concentrations, and toxicities in a pig model	5
Revisiting the meaning of Trousseau sign and syndrome	5
Improved bladder function in radical hysterectomy without worsening oncologic outcome: resection of the posterior layer of the vesicouterine ligament with the procedure limited to the vesical veins	5
Diagnostic significance and predictive efficiency of metabolic risk score for fertility-sparing treatment in patients with atypical endometrial hyperplasia and early endometrial carcinoma	5
Comparison of the safety between cervical conization and hysterectomy for patients with cervical adenocarcinoma in situ	5
Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: an	5
Efficacy and prognosis of robotic surgery with sentinel node navigation surgery in endometrial cancer	5
Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of O	5
Effectiveness of craniotomy and long-term survival in 35 patients with gestational trophoblastic neoplasia with brain metastases: a clinical retrospective analysis	5
The pathologic and clinical outcomes of risk-reducing salpingo-oophorectomy in asymptomatic carriers of homologous recombination repair gene mutation	5
Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study	5
Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer	5
Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)	5
Cost-effectiveness of pembrolizumab plus chemotherapy for advanced endometrial cancer	4
Intraoperative frozen pathology exam of Common iliac lymph nodes and Para-Aortic lymphadenectomy on the prognosis and quality of life for patients with IB2-IIA2 Cervical Cancer: trial protocol for a r	4
International cost-effectiveness analysis of chemoradiotherapy plus pembrolizumab for locally advanced cervical cancer	4
Poor accuracy of endometrial sampling in patients with uterine carcinosarcomas: a nationwide analysis	4
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial	4
Abnormal p53 expression is associated with poor outcomes in grade I or II, stage I, endometrioid carcinoma: a retrospective single-institute study	4
Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT)	4
Gut microbiome associated with PARP inhibitor efficacy in patients with ovarian cancer	4
Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics	4
PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia	4
Modified posterior pelvic exenteration combined with ileocecal resection for locally advanced endometrial cancer	4
Different surgical methods for FIGO stage IVB cervical cancer patients receiving chemotherapy: a population-based study	4
Impact of adjuvant treatment on survival in patients with 2023 FIGO stage IIC endometrial cancer: a retrospective analysis from two tertiary centers in Korea and Taiwan	4
Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study	4
An overview of the current debate between using minimally invasive surgery versus laparotomy for interval cytoreductive surgery in epithelial ovarian cancer	4
The course forward: next generation sequencing as part of the next generation management of patients with locally advanced cervical cancer	4
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Onco	4
Interleukin-34 cancels anti-tumor immunity by PARP inhibitor	4
Clinical trial comparing the use of Orcellex® Brush versus Cervex-Brush® on vaginal vault smear cytology adequacy rate in patients treated with radiotherapy for cervical cancer	4
Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience	4
Prognostic factors of dose-response relationship for nodal control in metastatic lymph nodes of cervical cancer patients undergoing definitive radiotherapy with concurrent chemotherapy	4
Erratum: Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer	4
Missing a chance to prevent: disparities in completion of genetic evaluation in high-risk patients with endometrial cancer	4
Reevaluating the vesicouterine pouch: histological evidence for optimal dissection planes in oncologic surgery	3
Cisplatin-induced PANDAR-Chemo-EVs contribute to a more aggressive and chemoresistant ovarian cancer phenotype through the SRSF9-SIRT4/SIRT6 axis	3
Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome	3
Circular RNA intraflagellar transport 80 facilitates endometrial cancer progression through modulating miR-545-3p/FAM98A signaling	3
Prognostic factors of adult granulosa cell tumors of the ovary: a Turkish retrospective multicenter study	3
Clinical outcome and pattern of care for isolated or incidental serous tubal intraepithelial carcinoma: a multicenter retrospective cohort study	3
Novel vaginoplasty technique involving the use of peritoneal flaps during laparoscopic radical hysterectomy for early-stage cervical cancer	3
Revision of quality indicators for cervical cancer and trend analysis of existing indicators in Japan	3
Correspondence on: The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter by Nicolai et al.	3
Role of adjuvant chemotherapy in stage IC ovarian granulosa cell tumors: a systematic review and meta-analysis	3

HPV vaccination status and effectiveness in Korean women with HPV16/18 infection (2010–2021): a retrospective study	3
Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer	3
Oncogenic pathway landscape of ovarian cancer and correlation with clinical prognosis	3
A predictive model for lymph node metastasis using tumor location in presumed early-stage endometrioid endometrial cancer patients	3
RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study	3
Efficacy of intra-abdominal cytoreductive surgery in advanced endometrial cancer with distant metastasis	3
Nodal surgery in early-stage cervical cancer: the PHENIX trial and the road ahead	3
Predictors of postoperative pancreatic fistula after splenectomy with or without distal pancreatectomy performed as a component of cytoreductive surgery for advanced ovarian cancer	3
HIPEC in recurrent ovarian cancer: flogging a tired HORSE?	3
Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting	3
ASGO 7th International Workshop on Gynecologic Oncology	3
FIGO staging of endometrial cancer: 2023	3
Oncologic outcomes according to the level of disease burden in patients with metachronous distant metastases from uterine cervical cancer: a Korean Radiation Oncology Group study (KROG 18-10)	3
TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR/ERK pathway	3
Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis	3
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician’s choice chemotherapy in patients with previously treated advanced or recurrent end	3
Integrated analysis of DNA methylome and transcriptome reveals SFRP1 and LIPG as potential drivers of ovarian cancer metastasis	3
Letter to editor regarding the published manuscript: “A prospective comparison of the diagnostic accuracies of ultrasound and magnetic resonance imaging in preoperative staging of endometrial cancer”	3
SLAMF7 predicts prognosis and correlates with immune infiltration in serous ovarian carcinoma	3
Diagnostic performances of the Ovarian Adnexal Reporting and Data System, the Risk of Ovarian Malignancy Algorithm, and the Copenhagen Index in the preoperative prediction of ovarian cancer: a prospec	3
Expert commentary on HORSE/MITO18 and CHIPOR	3
Knowledge and awareness of cervical cancer and prevention measures among female students in Poland: a cross-sectional, decade apart study	3
Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic	3
Planning and performing simultaneous bariatric surgery and robotic hysterectomy in a super-obese patient with endometrial cancer	2
Application value of personalized 3D printing vaginal model for the Image-guided adaptive brachytherapy of cervical cancer	2
Impact of peritoneal vaginoplasty combined with radical hysterectomy on the quality of sexual life for patients with early-stage cervical cancer: trial protocol for a multi-center superiority randomiz	2
LncRNA STARD7-AS1 suppresses cervical cancer cell proliferation while promoting autophagy by regulating miR-31-5p/TXNIP axis to inactivate the mTOR signaling	2
ATF1 regulates MAL2 expression through inhibition of miR-630 to mediate the EMT process that promotes cervical cancer cell development and metastasis	2
The prognosis impact of NACT-IDS and PDS in advanced ovarian cancer: a systematic review and meta-analysis	2
Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)	2
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement	2
Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer	2
Quality indicators for endometrial cancer care in Japan	2
Comparison of immediate germline sequencing and multi-step screening for Lynch syndrome detection in high-risk endometrial and colorectal cancer patients	2
Early prediction and risk stratification of ovarian cancer based on clinical data using machine learning approaches	2
Epidemiologic characteristics and a prognostic nomogram for patients with vulvar cancer: results from the Surveillance, Epidemiology, and End Results (SEER) program in the United States, 1975 to 2016	2
Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCR	2
Accuracy of human papillomavirus tests on self-collected urine versus clinician-collected samples for the detection of cervical precancer: a systematic review and meta-analysis	2
Global burden of uterine cancer in 204 countries and territories and its predicted level in 15 years, from 1990 to 2021	2
Evaluation of autophagy related ATG4B gene, protein and miR-655-3p expression levels in endometrial cancer and hyperplasia	2
Simple hysterectomy SHAPE-ing up to be the treatment of choice for early cervical cancer under 2 cm	2
Retraction: Circ_0075960 targets the miR-202-5p/CTNND1 axis to promote the growth and migration of endometrial carcinoma cells via regulating Wnt/β-catenin signaling activity	2
Is it time to change surgery for early-stage low-risk cervical cancer to simple hysterectomy?	2
Genetic analysis of cervical cancer with lymph node metastasis	2
Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines	2
AP2α negatively regulates PDHA1 in cervical cancer cells to promote aggressive features and aerobic glycolysis in vitro and in vivo	2
Book Review: IARC handbooks of cancer prevention, volume 18: Cervical cancer screening	2
Conditional relative survival of patients with endometrial cancer: a Korean National Cancer Registry study	2
UPF1 inhibits cervical cancer cell migration and invasion by regulating nonsense-mediated decay of BMP6 and lncRNA WAKMAR2	2
Effect of quality control program on surgical management in advanced ovarian cancer	2
Asian Young Doctors Session at the 64th Annual Meeting of the Japanese Society for Gynecologic Oncology (JSGO): Educational Initiatives in the Next Generation for a New Era after the COVID-19 Pandemic	2
Ovarian squamous cell carcinoma: clinicopathological features, prognosis and immunotherapy outcomes	2
Oncologic outcome of metachronous oligometastatic recurrence in advanced cervical cancer patients after primary radio-chemotherapy	2
Airborne and surface contamination after rotational intraperitoneal pressurized aerosol chemotherapy using cisplatin	2
Management for perioperative complications of diaphragmatic surgery in ovarian cancer at a Chinese tertiary cancer center	2
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer	2
The prognostic significance of primary tumor site in vulvar cancer: a population-based cohort study	2
Regularity of cervical cancer screening in Korea: analysis using national public data for 12 years	2
Where is ERAS in the management of advanced ovarian cancer?: between myths and truths	2
Evaluating the specific STAT3 inhibitor YHO-1701 in ovarian cancer cell lines and patient-derived cell models: efficacy, mechanisms, and therapeutic potential	2
Reviewer recognition in 2022	2
Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas	2
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study	2
Prevalence of high-risk human papillomavirus genotypes among women in Uzbekistan, 2021–2023	2
The value of surgery and the prognostic factors for patients with recurrent low-grade endometrial stromal sarcoma: a retrospective study of 38 patients	2
Immunonutrition in ovarian cancer: clinical and immunological impact?	2
FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinoma	2